Resistance-repellent retroviral protease inhibitors
US7807845B2 · kind B2 · utility
1Cited by
11References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 2005 |
| Grant date | Oct 5, 2010 |
| Priority date | — |
| Expiry date | Aug 12, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D209/34
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Resistance-repellent and multidrug resistant retroviral protease inhibitors are provided. Pharmaceutical composition comprising such compounds, and methods of using such compounds to treat HIV infections in mammals, are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.